Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-012048
Filing Date
2016-08-17
Accepted
2016-08-17 12:19:25
Documents
33
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bkit_10q.htm 10-Q 145530
2 CERTIFICATION bkit_ex311.htm EX-31.1 8487
3 CERTIFICATION bkit_ex321.htm EX-32.1 2795
  Complete submission text file 0001477932-16-012048.txt   803000

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bkit-20160531.xml EX-101.INS 82215
5 XBRL TAXONOMY EXTENSION SCHEMA bkit-20160531.xsd EX-101.SCH 13040
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bkit-20160531_cal.xml EX-101.CAL 20908
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkit-20160531_def.xml EX-101.DEF 8268
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkit-20160531_lab.xml EX-101.LAB 73171
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkit-20160531_pre.xml EX-101.PRE 56519
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 646-513-2776
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

EIN.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55022 | Film No.: 161837981
SIC: 7200 Services-Personal Services